We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+15.22%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$280M
AUM Growth
+$4.87M
Cap. Flow
-$17.4M
Cap. Flow %
-6.19%
Top 10 Hldgs %
28.7%
Holding
166
New
40
Increased
28
Reduced
35
Closed
35

Top Buys

Rank Stock Value
1
APGE icon
Apogee Therapeutics
APGE
+$5.21M
2
ANSS
Ansys
ANSS
+$4.33M
3
JNPR
Juniper Networks
JNPR
+$4.19M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$2.49M
5
SWTX
SpringWorks Therapeutics
SWTX
+$2.36M

Top Sells

Rank Stock Value
1
SYRE icon
Spyre Therapeutics
SYRE
+$12.3M
2
IMVT icon
Immunovant
IMVT
+$5.11M
3
IMGN
Immunogen Inc
IMGN
+$4.29M
4
SPLK
Splunk Inc
SPLK
+$4.2M
5
SOVO
Sovos Brands, Inc. Common Stock
SOVO
+$4.07M

Sector Composition

Rank Sector Weight
1 Healthcare 44.78%
2 Technology 11.84%
3 Consumer Discretionary 7.8%
4 Industrials 6.17%
5 Financials 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LI icon
126
Li Auto
LI
$12.4B
$396K 0.14%
13,066
+4,100
+46% +$136K
PHVS icon
127
Pharvaris
PHVS
$2.41B
$387K 0.14%
+16,750
New +$445K
TAL icon
128
TAL Education Group
TAL
$6.75B
$384K 0.14%
33,800
-15,200
-31% -$189K
CABA icon
129
Cabaletta Bio
CABA
$455M
$379K 0.14%
+22,208
New +$477K
KALV
130
DELISTED
KalVista Pharmaceuticals
KALV
$378K 0.13%
+31,873
New +$425K
BASE
131
DELISTED
Couchbase
BASE
$362K 0.13%
13,756
-4,570
-25% -$119K
ADBE icon
132
Adobe
ADBE
$105B
– –
-1,525
Closed -$910K
ALV icon
133
Autoliv
ALV
$8.96B
– –
-7,244
Closed -$798K
AMLX icon
134
Amylyx Pharmaceuticals
AMLX
$2.63B
– –
-26,349
Closed -$388K
CHTR icon
135
Charter Communications
CHTR
$18.8B
– –
-4,434
Closed -$1.72M
CSTM icon
136
Constellium
CSTM
$4.05B
– –
-42,294
Closed -$844K
ELV icon
137
Elevance Health
ELV
$84.7B
– –
-2,795
Closed -$1.32M
FSV icon
138
FirstService
FSV
$6.3B
– –
-6,500
Closed -$1.05M
LKFT
139
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.88B
– –
-12,953
Closed -$527K
HUBS icon
140
HubSpot
HUBS
$11B
– –
-2,200
Closed -$1.28M
IMVT icon
141
Immunovant
IMVT
$8.45B
– –
-121,287
Closed -$5.11M
INVH icon
142
Invitation Homes
INVH
$17.7B
– –
-32,000
Closed -$1.09M
IONS icon
143
Ionis Pharmaceuticals
IONS
$9.21B
– –
-57,348
Closed -$2.9M
JBHT icon
144
JB Hunt Transport Services
JBHT
$24.9B
– –
-5,700
Closed -$1.14M
LLY icon
145
Eli Lilly
LLY
$1.08T
– –
-2,300
Closed -$1.34M
PATH icon
146
UiPath
PATH
$8.14B
– –
-123,675
Closed -$3.07M
PODD icon
147
Insulet
PODD
$10B
– –
-5,700
Closed -$1.24M
RBC icon
148
RBC Bearings
RBC
$17.5B
– –
-4,200
Closed -$1.2M
ROP icon
149
Roper Technologies
ROP
$39.5B
– –
-2,413
Closed -$1.32M
SERA icon
150
Sera Prognostics
SERA
$77.9M
– –
-20,480
Closed -$122K
3 4 5
6
7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q1 2024 Portfolio in Review

As of Q1 2024, HighVista Strategies held 166 positions worth $280M, up 1.8% from $276M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HighVista Strategies withdrew a net $17.4M in Q1 2024, closing 35 positions and reducing 35 holdings. Its most notable exit was Immunovant, an estimated $5.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, HighVista Strategies opened a new position in Apogee Therapeutics worth $7.93M.

  • HighVista Strategies's largest Q1 2024 buy was Apogee Therapeutics: 119,403 shares worth $7.93M.
  • HighVista Strategies added most to argenx in Q1 2024, an estimated $2.2M increase.
  • HighVista Strategies's biggest Q1 2024 reduction was Spyre Therapeutics, cutting an estimated $12.3M.
  • HighVista Strategies fully exited Immunovant in Q1 2024, selling an estimated $5.11M.
  • HighVista Strategies's ten largest holdings make up 29% of its $280M portfolio in Q1 2024.
  • HighVista Strategies opened 40 new positions and closed 35 in Q1 2024.
  • HighVista Strategies's portfolio value rose 1.8% quarter-over-quarter to $280M.

Based on HighVista Strategies's 13F filing for Q1 2024, filed 15 May 2024.